Volumetric analysis of central body fat accurately predicts incidence of diabetes and hypertension in adults by unknown
Gibby et al. BMC Obesity  (2015) 2:10 
DOI 10.1186/s40608-015-0039-3RESEARCH ARTICLE Open AccessVolumetric analysis of central body fat accurately
predicts incidence of diabetes and hypertension
in adults
Jacob T Gibby1, Dennis K Njeru4, Steven T Cvetko4, Ray M Merrill2, Benjamin T Bikman1* and Wendell A Gibby3,4Abstract
Background: Central adipose tissue is appreciated as a risk factor for cardiometabolic disorders. The purpose of
this study was to determine the efficacy of a volumetric 3D analysis of central adipose tissue in predicting disease.
Full body computerized tomography (CT) scans were obtained from 1225 female (518) and male (707) subjects,
aged 18–88. Percent central body fat (%cBF) was determined by quantifying the adipose tissue volume from the
dome of the liver to the pubic symphysis. Calcium score was determined from the calcium content of coronary
arteries. Relationships between %cBF, BMI, and several cardiometabolic disorders were assessed controlling for age,
sex, and race.
Results: Higher %cBF was significantly greater for those with type 2 diabetes and hypertension, but not stroke
or hypercholesterolemia. Simple anthropometric determination of BMI equally correlated with diabetes and
hypertension as central body fat. Calcium scoring significantly correlated with all measurements of cardiovascular
health, including hypertension, hypercholesterolemia, and heart disease.
Conclusions: Central body fat and BMI equally and highly predict incidence of hypertension and type 2 diabetes.
Keywords: Volumetric Analysis, CT Scan, Obesity, Diabetes, HypertensionBackground
The consistent and robust increased risk of multiple dis-
eases associated with body fat has led to greater appreci-
ation of adipose tissue analysis. Excess body fat increases
risk of certain cancers [1], diabetes [2], hypertension [2],
and cognitive dysfunction [3]. Considering the substan-
tial economic and personal burden of these diseases, and
the increasing worldwide trends of obesity [4,5], the
ability to detect and ultimately mitigate weight gain is
paramount. The majority of research has focused on
whole body fat, employing various classic (e.g., Body
Mass Index (BMI), underwater weighing [6]) and mod-
ern (e.g., dual-energy X-ray absorptiometry [7]) methods.
However, research in recent decades has benefitted from
identifying distinct fat depots by again using both simple
(e.g., waist circumference, waist-to-hip ratio [8]) and
complex (e.g., magnetic resonance imaging (MRI) [9])* Correspondence: benjamin_bikman@byu.edu
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unless otherwise stated.techniques. Among the multiple sites of fat storage on
the body, the greatest advance has been the ability to
quantify internal fat depots, in particular central fat, via
MRI [9] and computed tomography [10], which is im-
portant given the evidence suggesting the pathological
role of central fat in various disease states [11]. Thus,
improved methods of quantifying central fat may be use-
ful in determining risk of related diseases.
Despite its acceptance and validation [12], there is a
broad range of analytical methodologies in determining
abdominal adiposity via computerized tomography (CT)
imaging that has complicated its widespread application.
The common practice is to extrapolate central body fat
amount through a single CT slice [13,14]. The purpose
of this study was to validate the use of assessing central
body fat via CT with regards to cardiometabolic disease
risk. To this end, we employed a novel volumetric ana-
lysis to quantify abdominal fat in men and women and
measured its correlation with several diseases associatedThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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spread acceptance of coronary artery calcium scoring in
assessing cardiovascular disease [15], we also included
calcium scoring to determine its ability to predict pa-
tients with cardiometabolic diseases.
Methods
Patients
Analyses are based on 1225 patients who received full
body CT scans using a 4-slice multi-detector GE Light-
speed CT scanner (Milwaukee, Wisconsin) at Accuscan
Health Imaging Center. Histories and clinical informa-
tion of patients were prepared and given by Accuscan
Health Imaging Center. All subjects were 18 years of age
or older. Both pre and postmenopausal women were
included in the study. The majority of patients were
Caucasian. The data were collected from patients receiv-
ing routine check-up CT scans and providing informed
consent. The study was approved by the Brigham Young
University Institutional Review Board.
Clinical information
Clinical information was self-reported by answering a
questionnaire. Hypertension was defined as having a his-
tory of hypertension for at least one year (i.e., blood
pressure > 140/90 mmHg). Diabetes was defined as a
patient clinically diagnosed with type 2 diabetes mellitus
(i.e., blood glucose >126 mg/dl) and requiring insulin or
oral hypoglycemic drugs. Heart disease was defined as a
patient having had a heart attack, coronary bypass, heart
stent, or percutaneous transluminal coronary angioplasty
(PTCA). High Cholesterol was defined as total choles-
terol above 200 mg/dL or requiring lipid-lowering drugs.
Stroke was defined as a patient having had a stroke in
their lifetime. Cancer was defined as a patient having
been clinically diagnosed with cancer in their lifetime.
Body mass index was calculated as body mass (kg)
divided by height2 (m) [16].
Scan parameters
All subjects were scanned in the supine position. The
tube voltage was set at 140 kV, and the current varied
between 100–360 mA (5-95th percentile) depending on
the weight of the patient. Each subject was scanned in a
large field view with 5 mm thick scans, with a 5 mm
interval. Reconstructive images were created every 2.5
mm to enhance detail and limit noise. The CT scanner
was calibrated each day with standard phantoms. Water
was set to a density of 0 according to the Hounsfield
Scale [17].
Hounsfield scale
An algorithm was designed to measure pixel intensity in
CT scans correlated to types of body tissue. The pixelintensities used to distinguish various tissues were derived
from their corresponding intensities, which were com-
puted using the Hounsfield scale. The Hounsfield scale re-
lates relative densities given in Hounsfield Units (HU);
water is equal to 0, air is equal to −1000, bone is approxi-
mately +700 to +3000, and fat is approximately −100
to −50 [17]. In measuring percent central body fat (%cBF),
we used a range of −150 HU to −15 HU to represent adi-
pose tissue. We neglected the range of −15 HU to 0 HU.
Body range was set at −150 HU to +3000 HU.
A notable challenge is defining a pixel containing tis-
sues of disparate densities [18]. This is common in the
lumen of the digestive tract and dermis. False-positive
fat pixels would arise on the boundary between air and
higher-density tissues. To test the false positive volume
percentage, we analyzed all regions containing air by one
pixel and count the number of pixels also labeled as
adipose tissue. In analyzing scans from 10 randomly
selected patient samples (via random number generation),
we determined a mean, false-positive rate of 2.64%. While
this is a potentially significant percentage, the standard de-
viation was 0.44%, indicating that nearly all patients had
relatively the same percent false positive.Calcium scoring
Chest CT scans were used by a certified technician to
determine calcium scoring. Each scan was implemented
in the workstation interface for the CT scanner previ-
ously mentioned. Coronary artery calcium score was
assessed according to a predefined phantom standard
[19,20]. The Agatston score was then used to determine
and scale calcium scoring [21].Percent central body fat measurement
Percent central body fat (%cBF) is an in-house term to
indicate the percentage of adipose tissue from the dome
of the liver to the pubic symphysis. This includes the
intra-abdominal, retroperitoneal, mesenteric, and omen-
tal fat regions, as described [22]. Percent central body fat
was determined using a Novarad® NovaPACS (Picture
Archiving and Computing System) 3D workstation. Our
algorithm is applied to a 3D CT dataset. The user can
narrow the region of interest by adjusting 6 sides of an
enclosed box. To standardize the location of measure-
ments, we set bounds of the CT 3D rendering from the
dome of the liver to the bottom of the pubic symphysis. All
other dimensions were extended to include the entire abdo-
men. The tissues are presented as volume in liters (L) by:
Tissue volume ¼ Tissue Pixel Count
 Pixel Volume
Gibby et al. BMC Obesity  (2015) 2:10 Page 3 of 8The percentage body tissue is thus computed by:
%Tissue ¼ ð∑tissue pixels =∑body pixelsÞ  100
The %cBF of each subject was estimated. The software
automatically excludes any pixels containing air in lung,
bowel lumen, or exterior to the body. A typical 2D
snapshot of the 3D rendering software used on the
NovaPACS system is shown in Figure 1.
Statistical techniques
Frequencies, means, and standard deviations were used to
describe the data. Regression analysis was used to assess
the association between BMI and selected biometric vari-
ables and current and former smoking status, adjustingFigure 1 A typical 2D snapshot of the 3D rendering from a CT scan u
and 3D rendering (D) images are displayed. On the right, %cBF has been c
other body tissue depicted in green, and air depicted in black. Coronal (E),for age, sex, and race. The race variable represented 1164
(95.02%) Caucasians and 61 (4.98%) other. The other cat-
egory consisted of 12 Asians, 10 Hispanics, 9 of other race,
and 30 with unknown race. Regression analysis was also
used to assess the association between %cBF and se-
lected biometric variables and current and former
smoking status, adjusting for age, sex, and race. The
probability of diabetes given the subject had hyperten-
sion was compared with the probability of diabetes
given the subject did not have hypertension. The abil-
ity for BMI to predict diabetes and hypertension was
evaluated using different cut points for BMI. True
positive (sensitivity) was compared with false positives
(1-specificity) at each cut point and graphed using a
receiver operating characteristic (ROC) curve. This
was also done with different cut points for percent
body fat. Two-sided tests of significance were basedsing NovaPACS. On the left, normal coronal (A), sagittal (B), axial (C),
alculated in our set bounds with adipose tissue depicted in blue, all
sagittal (F), axial (G), and 3D rendering (H) images are depicted.
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ciation. Analyses were performed using SAS version
9.3 (SAS Institute Inc., Cary, NC, USA, 2010).
Results
Study subjects ranged in age from 18 to 88 (M = 53.4
y, SD = 10.5). Body Mass Index (BMI) ranged from
16.7 to 53.2 (M = 27.5 kg/m2, SD = 4.9) and percent
central body fat (%cBF) ranged from 13.9 to 73.2
(M = 48.3%, SD = 9.3). The majority of subjects were
men (707, 57.7%) compared with women (518, 42.3%)
and Caucasian (1164, 95.0%). A description of selected
health measures and smoking behavior is presented in
Table 1. Hypertension and high cholesterol were the most
common health problems, followed by diabetes and then
cancer; heart disease and stroke were least common. The
table also shows mean BMI, %cBF, and calcium score by
the selected health measures and smoking behavior. All










Yes 222 18.1 29.3 <0.00
No 1003 81.9 27.1
Diabetes
Yes 88 7.2 31.0 <0.00
No 1137 92.8 27.3
Heart disease
Yes 37 3.0 27.7 0.791
No 1188 97.0 27.5
High cholesterol
Yes 240 19.6 27.8 0.360
No 984 80.4 27.5
Stroke
Yes 6 0.5 25.7 0.358
No 1219 99.5 27.5
Cancer
Yes 54 4.4 28.0 0.476
No 1171 95.6 27.5
Current smoker
Yes 85 6.9 26.0 0.060
No 1140 93.1 27.0
Former smoker
Yes 220 18.0 27.6 0.025
No 1005 82.0 26.8
*Adjusting for age, sex, and race. †From the F statistic based on type III sums of squwith hypertension and former smokers. Mean BMI and %
cBF were significantly greater for those with diabetes and
hypertension. Mean calcium score was the only of the
three outcome measures to distinguish heart disease.
Overall, mean BMI was 27.5 kg/m2 (SD = 4.9), mean %
cBF was 48.3% (SD = 0.3), and mean calcium score was
137.2 (SD = 432). Body mass index and %cBF were
strongly correlated (Pearson correlation coefficient = 0.61,
p < 0.0001). Calcium score was very slightly positively
correlated with BMI (Pearson correlation coefficient =
0.08, p = 0.0073), but not with %cBF (p = 0.1165).
Regression analysis was performed for those variables
significantly associated with BMI and %cBF, adjusting
for age, sex, and race (Table 2). In particular, our
data indicate individuals classified as overweight or
obese based on BMI have a two- and threefold in-
creased likelihood of hypertension compared with
those of normal weight, respectively. The percent of






01 50.8 <0.0001 205.8 0.0001
47.8 87.0
01 52.1 <0.0001 159.2 0.2085
48.0 102.2
1 48.6 0.8232 539.0 <0.0001
48.3 95.0
0 48.8 0.3342 199.3 0.0001
48.2 84.1
7 48.0 0.9318 0 0.5155
48.3 105.8
0 48.5 0.8708 129.4 0.6632
48.3 104.6
8 47.6 0.1586 111.1 0.8949
48.9 105.0
0 50.0 0.0215 162.6 0.0175
48.5 90.4
ares.
Table 2 Body mass index, percent central body fat and calcium scores according to selected variables














Hypertension 2.14 0.36 <0.0001 3.06 0.64 <0.0001 −118.9 30.73 0.0001
Heart disease −0.21 0.81 0.7911 −0.32 1.43 0.8232 −444.1 68.34 < 0.0001
High cholesterol −0.32 0.35 0.3600 −0.61 0.63 0.3342 −115.3 29.93 0.0001
Diabetes 3.73 0.53 <0.0001 4.09 0.95 <0.0001 −57.0 45.26 0.2085
Former smoker 0.8 0.36 0.0250 1.47 0.64 0.0215 −72.2 30.34 0.0175
*Adjusting for age, sex, and race. †From the F statistic based on type III sums of squares. Fifteen different models are represented in the table.
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(Figure 3). Hence, both hypertension and diabetes
similarly show a strong positive association with BMI
and %cBF.
Each of the adjusted models represented in Table 2
were further assessed for significant interaction
terms involving each of the main independent vari-
ables (i.e., hypertension, heart disease, high choles-
terol, diabetes, and former smoker) and age, sex and
race. Interaction terms involving sex and race were
not significant in any of the 15 models. On the
other hand, two interaction terms involving age were
significant. In the model with BMI and former
smoking status (yes vs. no), a significant interaction
was present (p = 0.0460) involving former smoking
and age. In the model with %cBF and former smok-
ing status, a significant interaction was also present
(P = 0.0020) between former smoking and age. The
age variable is normally distributed, with both the
mean and median equal to 53. Using age 53 as the
cut point, the following table shows that the associ-
ation between former smoking and BMI or %cBF is
positive for ages < 53, but no association exists for
ages 53+ (Table 3).Figure 2 Percent of subjects with hypertension or diabetes
by BMI classification. Normal: 18–24; Overweight: 25–29; Obese 1:
30–34; Obese 2: 35 + .Receiver Operating Characteristic (ROC) curves
were derived for different BMI cut points and different
%cBF cut points. Figure 4 shows the ROC curve for
hypertension and Figure 5 shows the ROC curve for
diabetes. The line connecting the 0,0 point to the 1,1
point on the graphs represents where there is no pre-
dictive value in the test for hypertension or diabetes.
Cut points reflected by dots in the direction of the 0,1
point on the graphs are predictive, with those closer
to this upper-left hand corner of the graph superior. A
BMI cut point of 28 and a %cBF of 45 does the best
job detecting hypertension. A BMI cut point of 30 and
a %cBF of 55 does the best job detecting diabetes.Discussion
The purpose of this study was to determine the effi-
cacy of a novel and highly sensitive method of deter-
mining central adipose in predicting chronic disease.
We found that %cBF significantly correlated with type
2 diabetes mellitus and hypertension, but not other
selected chronic cardiometabolic diseases, such as
stroke or hypercholesterolemia. Body mass index was
similarly correlated with the same two diseases (i.e.,
diabetes and hypertension), and was at least asFigure 3 Percent of subjects with hypertension or diabetes by
percent central fat classification.
Table 3 Body mass index and percent central body fat according to former smoking status
BMI correlations Slope estimate Standard error P-value %BF correlations Slope estimate Standard error P-value
<53 1.56 0.55 0.0048 <53 3.38 1.06 0.0015
53+ 0.31 0.48 0.5223 53+ 0.25 0.29 0.7702
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assessment of abdominal adiposity.
Heart disease is the leading cause of death in the U.S.
[23]. Of the myriad factors that increase risk of heart
disease, we measured prevalence of the four main
modifiable factors, namely hypertension, smoking status,
dyslipidemia, and diabetes [24], through questionnaire.
While actual incidence of heart disease was not
correlated with %cBF in our study, we did observe a
significant correlation with hypertension, diabetes, and
former smoking status. The lack of a correlation with
heart disease may be a function of age; age is consid-
ered the most critical risk factor [25] and our patients
are younger than patients in several similar studies.
Another important distinction is our method; whereas
the majority of published results use a single-slice scan
of the abdomen to assess central fat, our method
includes a multiple scan 3D rendering, allowing con-
clusive volumetric determination of central fat mass.
These differences in analysis may explain disparate re-
sults from previous work [26].
Due to the high presence of calcium in atheroscler-
otic plaque, calcium scoring is accurate in predicting
incidence of cardiovascular burden [27]. Our results
corroborate previous work [28]; we found that calcium
score accurately distinguishes hypertension, high chol-
esterol, heart disease, and former smoking. It is
consistent with %cBF and BMI in distinguishing
hypertension and former smoking. However, unlike %
cBF and BMI, calcium score does not adequately dis-
tinguish diabetes.Figure 4 ROC curves for hypertension.Our findings of a consistent and significant relation
between percent central fat and diabetes and hyper-
tension are not surprising—these two variables are
consistently observed together [29] with clear and
common etiologies. The overwhelming majority of
evidence supports a causal relationship wherein dia-
betes precedes the development of hypertension [29],
though there is limited evidence to the opposite [30].
A critical mediator that links diabetes and hyperten-
sion is insulin resistance. Indeed, insulin resistance,
which is the key pathological event in the development
of diabetes, mediates multiple pathological processes
in the development of hypertension, including Na+
retention, sympathetic nervous system activation,
proliferation of vascular smooth muscle cells, and loss
of nitric oxide-induced vasodilation [29,31]. Moreover,
blood pressure improves with insulin-sensitizing medica-
tion [32]. However, insulin resistance is often undiag-
nosed due to the possibility of an insulin-resistant
patient to have normal blood glucose. Thus, a poten-
tial utility of quantifying central body fat may be in
detecting a patient who is at risk of developing or
already has insulin resistance. This will require further
studies to validate.
Cigarette smoking is recognized as a cause of insu-
lin resistance [33]. Given the mediating role of insu-
lin resistance in a host of cardiometabolic diseases,
this observation indicates that insulin resistance may
be the mediating mechanism whereby smoking re-
sults in dyslipidemia [31], hypertension [31,34], ath-
erosclerosis [31,34], and hepatic steatosis [35]. This
Figure 5 ROC curves for diabetes.
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to suffer hypertension than non-smokers. The lack
of evidence linking smoking and diabetes may be a
consequence of sample size in the current study.
However, it may also be that by relying on diagnosis
of diabetes, which is based solely on blood glucose
values above 126 mg/dL, we may be missing patients
who are pre-diabetic. Also, while smokers are gener-
ally considered to be leaner than nonsmokers, BMI
and visceral fat were similar between smokers and
nonsmokers. However, in corroboration with other
reports [36], former smokers over 55 years of age
had higher BMI and central body fat.
A weakness is the inherent self-selection of this
study; subjects voluntarily came to the clinic for a
check-up. Moreover, our assessment of disease was based
on self-reported data, not actual in-clinic measurements
(e.g., cholesterol, blood pressure). Moreover, our sub-
ject population is almost entirely Caucasian. This is
noteworthy considering that ethnicity carries not only
an inherent disparate propensity towards central
adiposity [37], but also likelihood of developing subse-
quent disease [38]. Thus, our findings should be
interpreted with caution when applied to diverse
ethnicities.Conclusion
In conclusion, a main motive for this study was to
determine whether quantification of central body
fat might reveal a novel predictive diagnostic for
chronic diseases. In light of our findings, analysis of
central body fat may serve as an early marker of
future disease onset. In other words, a patient with
increased central body fat, but neither diabetes
nor hypertension currently, may be warned of an
increased disease risk in the absence of lifestyle
changes. Our findings of similar predictive power
with measuring percent central body fat and BMIare noteworthy. While much discussion has centered
on the importance of central body fat, and we agree
with this sentiment, it is important for physicians to
bear in mind the efficacy of BMI to predict diabetes
and hypertension. Despite the inherent flaw of BMI
to ‘misdiagnose’ overweight or obesity in lean, mus-
cled individuals, BMI can be used as a surprisingly
accurate marker of visceral fat [39]. In particular,
our data indicate individuals classified as overweight
or obese based on BMI have a two- and threefold
increased likelihood of hypertension compared with
normal weight, respectively. The likelihood of devel-
oping diabetes is even greater in the overweight and
obese, four- and nine-fold higher, respectively. In the
end, these data add to the chorus of warning against
the dangers of excess central adipose and validate
the utility of simple anthropometry in determining
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